{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T02:46:05Z","timestamp":1791773165229,"version":"4.3.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"36","license":[{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2025,9,22]]},"DOI":"10.1038\/s41388-025-03494-x","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T19:47:53Z","timestamp":1752608873000},"page":"3333-3349","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Steroid receptor coactivator-1 facilitates METTL3-mediated m6A modification by coactivating NF-\u03baB and promotes the malignant progression of glioblastoma"],"prefix":"10.1038","volume":"44","author":[{"given":"Liang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7150-2120","authenticated-orcid":false,"given":"Ke","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmei","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuke","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2021-3817","authenticated-orcid":false,"given":"Miaomiao","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongshun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7109-6703","authenticated-orcid":false,"given":"Yuhui","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,15]]},"reference":[{"key":"3494_CR1","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1001\/jamaoncol.2022.2844","volume":"8","author":"TR Berger","year":"2022","unstructured":"Berger TR, Wen PY, Lang-Orsini M, Chukwueke UN. World Health Organization 2021 classification of central nervous system tumors and implications for therapy for adult-type gliomas: a review. JAMA Oncol. 2022;8:1493\u2013501.","journal-title":"JAMA Oncol"},{"key":"3494_CR2","doi-asserted-by":"publisher","first-page":"E20","DOI":"10.3171\/2020.10.FOCUS20744","volume":"50","author":"GMV Barbagallo","year":"2021","unstructured":"Barbagallo GMV, Certo F, Di Gregorio S, Maione M, Garozzo M, Peschillo S, et al. Recurrent high-grade glioma surgery: a multimodal intraoperative protocol to safely increase extent of tumor resection and analysis of its impact on patient outcome. Neurosurg Focus. 2021;50:E20.","journal-title":"Neurosurg Focus"},{"key":"3494_CR3","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1002\/cac2.12361","volume":"42","author":"E Verdugo","year":"2022","unstructured":"Verdugo E, Puerto I, Medina MA. An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatment. Cancer Commun. 2022;42:1083\u2013111.","journal-title":"Cancer Commun"},{"key":"3494_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08737-6","volume":"10","author":"Y Yang","year":"2019","unstructured":"Yang Y, van der Klaauw AA, Zhu L, Cacciottolo TM, He Y, Stadler LKJ, et al. Steroid receptor coactivator-1 modulates the function of Pomc neurons and energy homeostasis. Nat Commun. 2019;10:1718.","journal-title":"Nat Commun"},{"key":"3494_CR5","doi-asserted-by":"publisher","first-page":"38743","DOI":"10.1074\/jbc.R110.193367","volume":"285","author":"B York","year":"2010","unstructured":"York B, O\u2019Malley BW. Steroid receptor coactivator (SRC) family: masters of systems biology. J Biol Chem. 2010;285:38743\u201350.","journal-title":"J Biol Chem"},{"key":"3494_CR6","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1161\/ATVBAHA.107.145862","volume":"27","author":"S Sahar","year":"2007","unstructured":"Sahar S, Reddy MA, Wong C, Meng L, Wang M, Natarajan R. Cooperation of SRC-1 and p300 with NF-kappaB and CREB in angiotensin II-induced IL-6 expression in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2007;27:1528\u201334.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3494_CR7","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1159\/000066624","volume":"76","author":"TD Charlier","year":"2002","unstructured":"Charlier TD, Lakaye B, Ball GF, Balthazart J. Steroid receptor coactivator SRC-1 exhibits high expression in steroid-sensitive brain areas regulating reproductive behaviors in the quail brain. Neuroendocrinology. 2002;76:297\u2013315.","journal-title":"Neuroendocrinology"},{"key":"3494_CR8","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1161\/ATVBAHA.107.144477","volume":"27","author":"Y Yuan","year":"2007","unstructured":"Yuan Y, Xu J. Loss-of-function deletion of the steroid receptor coactivator-1 gene in mice reduces estrogen effect on the vascular injury response. Arterioscler Thromb Vasc Biol. 2007;27:1521\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3494_CR9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1073\/pnas.0808703105","volume":"106","author":"S Wang","year":"2009","unstructured":"Wang S, Yuan Y, Liao L, Kuang SQ, Tien JC, O\u2019Malley BW, et al. Disruption of the SRC-1 gene in mice suppresses breast cancer metastasis without affecting primary tumor formation. Proc Natl Acad Sci USA. 2009;106:151\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3494_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jsbmb.2013.02.010","volume":"138","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Duan C, Bian C, Xiong Y, Zhang J. Steroid receptor coactivator-1: a versatile regulator and promising therapeutic target for breast cancer. J Steroid Biochem Mol Biol. 2013;138:17\u201323.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"3494_CR11","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1038\/s41388-022-02308-8","volume":"41","author":"P Guo","year":"2022","unstructured":"Guo P, Chen Q, Peng K, Xie J, Liu J, Ren W, et al. Nuclear receptor coactivator SRC-1 promotes colorectal cancer progression through enhancing GLI2-mediated Hedgehog signaling. Oncogene. 2022;41:2846\u201359.","journal-title":"Oncogene"},{"key":"3494_CR12","doi-asserted-by":"crossref","unstructured":"Choi SR, Wang HM, Shin MH, Lim HS. Hydrophobic tagging-mediated degradation of transcription coactivator SRC-1. Int J Mol Sci. 2021;22:6407.","DOI":"10.3390\/ijms22126407"},{"key":"3494_CR13","doi-asserted-by":"publisher","first-page":"3692","DOI":"10.1158\/1078-0432.CCR-17-2615","volume":"24","author":"E Ward","year":"2018","unstructured":"Ward E, Vareslija D, Charmsaz S, Fagan A, Browne AL, Cosgrove N, et al. Epigenome-wide SRC-1-mediated gene silencing represses cellular differentiation in advanced breast cancer. Clin Cancer Res. 2018;24:3692\u2013703.","journal-title":"Clin Cancer Res"},{"key":"3494_CR14","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/cas.14685","volume":"112","author":"M Gong","year":"2021","unstructured":"Gong M, Wang X, Mu L, Wang Y, Pan J, Yuan X, et al. Steroid receptor coactivator-1 enhances the stemness of glioblastoma by activating long noncoding RNA XIST\/miR-152\/KLF4 pathway. Cancer Sci. 2021;112:604\u201318.","journal-title":"Cancer Sci"},{"key":"3494_CR15","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1139\/bcb-2018-0114","volume":"97","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Shi W. Steroid receptor coactivator-1 regulates glioma angiogenesis through polyomavirus enhancer activator 3 signaling. Biochem Cell Biol. 2019;97:488\u201396.","journal-title":"Biochem Cell Biol"},{"key":"3494_CR16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jsbmb.2012.04.005","volume":"132","author":"OT Hernandez-Hernandez","year":"2012","unstructured":"Hernandez-Hernandez OT, Gonzalez-Garcia TK, Camacho-Arroyo I. Progesterone receptor and SRC-1 participate in the regulation of VEGF, EGFR and Cyclin D1 expression in human astrocytoma cell lines. J Steroid Biochem Mol Biol. 2012;132:127\u201334.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"3494_CR17","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1101\/gad.262766.115","volume":"29","author":"Y Yue","year":"2015","unstructured":"Yue Y, Liu J, He C. RNA N6-methyladenosine methylation in post-transcriptional gene expression regulation. Genes Dev. 2015;29:1343\u201355.","journal-title":"Genes Dev"},{"key":"3494_CR18","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41422-018-0034-6","volume":"28","author":"X Deng","year":"2018","unstructured":"Deng X, Su R, Weng H, Huang H, Li Z, Chen J. RNA N(6)-methyladenosine modification in cancers: current status and perspectives. Cell Res. 2018;28:507\u201317.","journal-title":"Cell Res"},{"key":"3494_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1033-z","volume":"18","author":"XY Chen","year":"2019","unstructured":"Chen XY, Zhang J, Zhu JS. The role of m(6)A RNA methylation in human cancer. Mol Cancer. 2019;18:103.","journal-title":"Mol Cancer"},{"key":"3494_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01204-7","volume":"19","author":"T Wang","year":"2020","unstructured":"Wang T, Kong S, Tao M, Ju S. The potential role of RNA N6-methyladenosine in Cancer progression. Mol Cancer. 2020;19:88.","journal-title":"Mol Cancer"},{"key":"3494_CR21","doi-asserted-by":"crossref","unstructured":"Zheng ZH, Zhang GL, Jiang RF, Hong YQ, Zhang QY, He JP, et al. METTL3 is essential for normal progesterone signaling during embryo implantation via m6A-mediated translation control of progesterone receptor. Proc Natl Acad Sci USA. 2023;120:e2214684120.","DOI":"10.1073\/pnas.2214684120"},{"key":"3494_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1038-7","volume":"18","author":"T Li","year":"2019","unstructured":"Li T, Hu PS, Zuo Z, Lin JF, Li X, Wu QN, et al. METTL3 facilitates tumor progression via an m(6)A-IGF2BP2-dependent mechanism in colorectal carcinoma. Mol Cancer. 2019;18:112.","journal-title":"Mol Cancer"},{"key":"3494_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01289-0","volume":"19","author":"X Ying","year":"2020","unstructured":"Ying X, Jiang X, Zhang H, Liu B, Huang Y, Zhu X, et al. Programmable N6-methyladenosine modification of CDCP1 mRNA by RCas9-methyltransferase like 3 conjugates promotes bladder cancer development. Mol Cancer. 2020;19:169.","journal-title":"Mol Cancer"},{"key":"3494_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01471-y","volume":"21","author":"R Zheng","year":"2022","unstructured":"Zheng R, Zhang K, Tan S, Gao F, Zhang Y, Xu W, et al. Exosomal circLPAR1 functions in colorectal cancer diagnosis and tumorigenesis through suppressing BRD4 via METTL3-eIF3h interaction. Mol Cancer. 2022;21:49.","journal-title":"Mol Cancer"},{"key":"3494_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1065-4","volume":"18","author":"B Yue","year":"2019","unstructured":"Yue B, Song C, Yang L, Cui R, Cheng X, Zhang Z, et al. METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer. Mol Cancer. 2019;18:142.","journal-title":"Mol Cancer"},{"key":"3494_CR26","doi-asserted-by":"publisher","first-page":"4420","DOI":"10.1038\/s41388-022-02435-2","volume":"41","author":"QY Du","year":"2022","unstructured":"Du QY, Huo FC, Du WQ, Sun XL, Jiang X, Zhang LS, et al. METTL3 potentiates progression of cervical cancer by suppressing ER stress via regulating m6A modification of TXNDC5 mRNA. Oncogene. 2022;41:4420\u201332.","journal-title":"Oncogene"},{"key":"3494_CR27","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1158\/2159-8290.CD-20-0331","volume":"11","author":"D Dixit","year":"2021","unstructured":"Dixit D, Prager BC, Gimple RC, Poh HX, Wang Y, Wu Q, et al. The RNA m6A Reader YTHDF2 Maintains Oncogene Expression and Is a Targetable Dependency in Glioblastoma Stem Cells. Cancer Discov. 2021;11:480\u201399.","journal-title":"Cancer Discov"},{"key":"3494_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05933-7","volume":"14","author":"J Yin","year":"2023","unstructured":"Yin J, Ding F, Cheng Z, Ge X, Li Y, Zeng A, et al. METTL3-mediated m6A modification of LINC00839 maintains glioma stem cells and radiation resistance by activating Wnt\/beta-catenin signaling. Cell Death Dis. 2023;14:417.","journal-title":"Cell Death Dis"},{"key":"3494_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111530","volume":"41","author":"ZW Zhang","year":"2022","unstructured":"Zhang ZW, Teng X, Zhao F, Ma C, Zhang J, Xiao LF, et al. METTL3 regulates m(6)A methylation of PTCH1 and GLI2 in Sonic hedgehog signaling to promote tumor progression in SHH-medulloblastoma. Cell Rep. 2022;41:111530.","journal-title":"Cell Rep"},{"key":"3494_CR30","first-page":"1556","volume":"26","author":"J Han","year":"2021","unstructured":"Han J, Du S, Wu C, Qiu M, Su L, Zhao Z, et al. METTL3 participates in glioma development by regulating the methylation level of COL4A1. J BUON. 2021;26:1556\u201362.","journal-title":"J BUON"},{"key":"3494_CR31","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/onc.2017.351","volume":"37","author":"A Visvanathan","year":"2018","unstructured":"Visvanathan A, Patil V, Arora A, Hegde AS, Arivazhagan A, Santosh V, et al. Essential role of METTL3-mediated m(6)A modification in glioma stem-like cells maintenance and radioresistance. Oncogene. 2018;37:522\u201333.","journal-title":"Oncogene"},{"key":"3494_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.553","volume":"11","author":"F Li","year":"2021","unstructured":"Li F, Chen S, Yu J, Gao Z, Sun Z, Yi Y, et al. Interplay of m(6) A and histone modifications contributes to temozolomide resistance in glioblastoma. Clin Transl Med. 2021;11:e553.","journal-title":"Clin Transl Med"},{"key":"3494_CR33","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1177\/1947601910378024","volume":"1","author":"AR Wasylishen","year":"2010","unstructured":"Wasylishen AR, Penn LZ. Myc: the beauty and the beast. Genes Cancer. 2010;1:532\u201341.","journal-title":"Genes Cancer"},{"key":"3494_CR34","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1038\/s41388-021-01745-1","volume":"40","author":"K Fukasawa","year":"2021","unstructured":"Fukasawa K, Kadota T, Horie T, Tokumura K, Terada R, Kitaguchi Y, et al. CDK8 maintains stemness and tumorigenicity of glioma stem cells by regulating the c-MYC pathway. Oncogene. 2021;40:2803\u201315.","journal-title":"Oncogene"},{"key":"3494_CR35","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adh4181","volume":"15","author":"Q Mu","year":"2023","unstructured":"Mu Q, Chai R, Pang B, Yang Y, Liu H, Zhao Z, et al. Identifying predictors of glioma evolution from longitudinal sequencing. Sci Transl Med. 2023;15:eadh4181.","journal-title":"Sci Transl Med"},{"key":"3494_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2024.119716","volume":"1871","author":"XN Yuan","year":"2024","unstructured":"Yuan XN, Shao YC, Guan XQ, Liu Q, Chu MF, Yang ZL, et al. METTL3 orchestrates glycolysis by stabilizing the c-Myc\/WDR5 complex in triple-negative breast cancer. Biochim Biophys Acta Mol Cell Res. 2024;1871:119716.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"3494_CR37","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jare.2023.08.014","volume":"61","author":"S Guo","year":"2024","unstructured":"Guo S, Chen F, Li L, Dou S, Li Q, Huang Y, et al. Intracellular Fusobacterium nucleatum infection increases METTL3-mediated m6A methylation to promote the metastasis of esophageal squamous cell carcinoma. J Adv Res. 2024;61:165\u201378.","journal-title":"J Adv Res"},{"key":"3494_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.737498","volume":"9","author":"Y Shi","year":"2021","unstructured":"Shi Y, Dou Y, Zhang J, Qi J, Xin Z, Zhang M, et al. The RNA N6-methyladenosine methyltransferase METTL3 promotes the progression of kidney cancer via N6-methyladenosine-dependent translational enhancement of ABCD1. Front Cell Dev Biol. 2021;9:737498.","journal-title":"Front Cell Dev Biol"},{"key":"3494_CR39","doi-asserted-by":"publisher","first-page":"10831","DOI":"10.1074\/jbc.273.18.10831","volume":"273","author":"SY Na","year":"1998","unstructured":"Na SY, Lee SK, Han SJ, Choi HS, Im SY, Lee JW. Steroid receptor coactivator-1 interacts with the p50 subunit and coactivates nuclear factor kappaB-mediated transactivations. J Biol Chem. 1998;273:10831\u20134.","journal-title":"J Biol Chem"},{"key":"3494_CR40","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1158\/0008-5472.CAN-13-2939","volume":"74","author":"Y Wang","year":"2014","unstructured":"Wang Y, Lonard DM, Yu Y, Chow DC, Palzkill TG, Wang J, et al. Bufalin is a potent small-molecule inhibitor of the steroid receptor coactivators SRC-3 and SRC-1. Cancer Res. 2014;74:1506\u201317.","journal-title":"Cancer Res"},{"key":"3494_CR41","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18171","volume":"28","author":"Z Tong","year":"2024","unstructured":"Tong Z, Zhang Y, Guo P, Wang W, Chen Q, Jin J, et al. Steroid receptor coactivator 1 promotes human hepatocellular carcinoma invasiveness through enhancing MMP-9. J Cell Mol Med. 2024;28:e18171.","journal-title":"J Cell Mol Med"},{"key":"3494_CR42","doi-asserted-by":"publisher","first-page":"17548","DOI":"10.1002\/anie.202005004","volume":"59","author":"Y Lee","year":"2020","unstructured":"Lee Y, Heo J, Jeong H, Hong KT, Kwon DH, Shin MH, et al. Targeted degradation of transcription coactivator SRC-1 through the N-degron pathway. Angew Chem Int Ed Engl. 2020;59:17548\u201355.","journal-title":"Angew Chem Int Ed Engl"},{"key":"3494_CR43","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s13578-023-01148-7","volume":"13","author":"Z Qiao","year":"2023","unstructured":"Qiao Z, Li Y, Cheng Y, Li S, Liu S. SHMT2 regulates esophageal cancer cell progression and immune Escape by mediating m6A modification of c-myc. Cell Biosci. 2023;13:203.","journal-title":"Cell Biosci"},{"key":"3494_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-021-01159-6","volume":"13","author":"A Iaiza","year":"2021","unstructured":"Iaiza A, Tito C, Ianniello Z, Ganci F, Laquintana V, Gallo E, et al. METTL3-dependent MALAT1 delocalization drives c-Myc induction in thymic epithelial tumors. Clin Epigenet. 2021;13:173.","journal-title":"Clin Epigenet"},{"key":"3494_CR45","doi-asserted-by":"crossref","unstructured":"Visvanathan A, Patil V, Abdulla S, Hoheisel JD, Somasundaram K. N(6)-methyladenosine landscape of glioma stem-like cells: METTL3 is essential for the expression of actively transcribed genes and sustenance of the oncogenic signaling. Genes 2019;10:141.","DOI":"10.3390\/genes10020141"},{"key":"3494_CR46","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1093\/neuonc\/nov265","volume":"18","author":"KE Cahill","year":"2016","unstructured":"Cahill KE, Morshed RA, Yamini B. Nuclear factor-kappaB in glioblastoma: insights into regulators and targeted therapy. Neuro Oncol. 2016;18:329\u201339.","journal-title":"Neuro Oncol"},{"key":"3494_CR47","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.trecan.2020.04.003","volume":"6","author":"B Eluard","year":"2020","unstructured":"Eluard B, Thieblemont C, Baud V. NF-kappaB in the New Era of Cancer Therapy. Trends Cancer. 2020;6:677\u201387.","journal-title":"Trends Cancer"},{"key":"3494_CR48","doi-asserted-by":"crossref","unstructured":"Gao B, Guo L, Luo D, Jiang Y, Zhao J, Mao C, et al. Steroid receptor coactivator-1 interacts with NF-kappaB to increase VEGFC levels in human thyroid cancer. Biosci Rep. 2018;38:BSR20180394.","DOI":"10.1042\/BSR20180394"},{"key":"3494_CR49","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.1172\/JCI78544","volume":"125","author":"L Gao","year":"2015","unstructured":"Gao L, Rabbitt EH, Condon JC, Renthal NE, Johnston JM, Mitsche MA, et al. Steroid receptor coactivators 1 and 2 mediate fetal-to-maternal signaling that initiates parturition. J Clin Investig. 2015;125:2808\u201324.","journal-title":"J Clin Investig"},{"key":"3494_CR50","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.jcmgh.2021.05.007","volume":"12","author":"Y Feng","year":"2021","unstructured":"Feng Y, Dong H, Sun B, Hu Y, Yang Y, Jia Y, et al. METTL3\/METTL14 transactivation and m(6)A-dependent TGF-beta1 translation in activated Kupffer cells. Cell Mol Gastroenterol Hepatol. 2021;12:839\u201356.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"3494_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106442","volume":"184","author":"L Soumoy","year":"2022","unstructured":"Soumoy L, Ghanem GE, Saussez S, Journe F. Bufalin for an innovative therapeutic approach against cancer. Pharmacol Res. 2022;184:106442.","journal-title":"Pharmacol Res"},{"key":"3494_CR52","first-page":"2235","volume":"11","author":"T Liu","year":"2016","unstructured":"Liu T, Jia T, Yuan X, Liu C, Sun J, Ni Z, et al. Development of octreotide-conjugated polymeric prodrug of bufalin for targeted delivery to somatostatin receptor 2 overexpressing breast cancer in vitro and in vivo. Int J Nanomed. 2016;11:2235\u201350.","journal-title":"Int J Nanomed"},{"key":"3494_CR53","doi-asserted-by":"publisher","first-page":"212","DOI":"10.7150\/ijbs.8056","volume":"10","author":"S Shen","year":"2014","unstructured":"Shen S, Zhang Y, Wang Z, Gong LiuR. X. Bufalin induces the interplay between apoptosis and autophagy in glioma cells through endoplasmic reticulum stress. Int J Biol Sci. 2014;10:212\u201324.","journal-title":"Int J Biol Sci"},{"key":"3494_CR54","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1158\/1535-7163.MCT-17-1296","volume":"17","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Dong Y, Melkus MW, Yin S, Tang SN, Jiang P, et al. Role of P53-senescence induction in suppression of LNCaP prostate cancer growth by cardiotonic compound Bufalin. Mol Cancer Ther. 2018;17:2341\u201352.","journal-title":"Mol Cancer Ther"},{"key":"3494_CR55","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41416-020-01135-6","volume":"124","author":"L Yang","year":"2021","unstructured":"Yang L, Zhou F, Zhuang Y, Liu Y, Xu L, Zhao H, et al. Acetyl-bufalin shows potent efficacy against non-small-cell lung cancer by targeting the CDK9\/STAT3 signalling pathway. Br J Cancer. 2021;124:645\u201357.","journal-title":"Br J Cancer"}],"updated-by":[{"DOI":"10.1038\/s41388-026-03788-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000}}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03494-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03494-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03494-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T07:03:09Z","timestamp":1776322989000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03494-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":55,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2025,9,22]]}},"alternative-id":["3494"],"URL":"https:\/\/doi.org\/10.1038\/s41388-025-03494-x","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,15]]},"assertion":[{"value":"7 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: Following the publication of this article, the authors noted an error in the IP blots included in Figure 5F. The representative Co-IP blots for p50 in U87-MG cells and p65 in LN229 cells were inadvertently duplicated.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":9,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":10,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41388-026-03788-8","URL":"https:\/\/doi.org\/10.1038\/s41388-026-03788-8","order":12,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}